Long term steroid therapy in children - management and weaning

Warning

Objectives

To provide guidance on the management and monitoring of a child on long term exogenous steroid therapy who are at risk of secondary adrenal suppression.

Scope

This document applies to Children (<18 years old) within NHS Tayside on long term steroids.

Audience

Secondary care health care practitioners who have clinical involvement with children prescribed long term steroid therapy.

Calculate body surface area

Body Surface Area (BSA) is calculated from height and weight, using a validated formula. An online calculator can be found here. If height is not available, then an approximate BSA can be found via the British Society for Paediatric Endocinology and Diabetes Adrenal Insufficiency guidelines.

Determine risk

Physiological requirement

Physiological cortisol production is equivalent to approximately 10 mg/m2/day Hydrocortisone.

1mg of... Is equivalent to...
Prednisolone 4mg Hydrocortisone
Triamcinolone 5mg Hydrocortisone
Methylprednisolone 5mg Hydrocortisone
Deflazacort 3.3mg Hydrocortisone
Dexamethasone 27mg Hydrocortisone

All pharmacological doses of oral steroids used in clinical practice are greater than an individual's physiological requirement. The exception to this is when a child is taking hydrocortisone for known adrenal suppression, where doses are designed to mimic normal endogenous production.

 

Assessing Risk

Children treated with higher than physiological dose of steroid (>10 mg/m2/day hydrocortisone, or equivalent) are at risk of secondary adrenal suppression.

Risk increases with duration of therapy: >4 weeks therapy may cause secondary adrenal suppression. Children receiving >6 months therapy should be assumed to have secondary adrenal suppression until proven otherwise.

Concurrent treatment with other forms of steroid e.g. intra-articular, inhaled, topical, nasal, eye drops will increase the risk. The absence of cushingoid appearance does not mean that the patient is not at risk of adrenal suppression. However, if a child has cushingoid appearance, he/she should be assumed to have adrenal suppression.

Calculate emergency plan

Children who have receive >= 6 months of steroid therapy should be assumed to have secondary adrenal insufficiency until proven otherwise.

Symptoms of adrenal insufficiency

  • Significantly tired/lethargy
  • Weight gain/weight loss
  • Multiple and increased frequency of intercurrent illnesses (taking longer to recover)
  • Adrenal crisis when unwell - hypoglycaemia, hypotension, vomiting.

 

All children on oral steroids and who are likely to remain on treatment for >6 months should be provided with an emergency plan for use during intercurrent illness, especially when unable to tolerate steroids due to vomiting. Note that this emergency plan should be modified during weaning process (see "Discontinuing steroids").

If a child is taking supraphysiological doses of Hydrocortisone (i.e. >30mg/m2/d) or equivalent (see "determine risk" for steroid conversions) and are tolerating oral medication, they should be advised to continue taking their normal dose of steroids. If on pulsed steroid therapy, they should continue/restart their normal dose.

If a child is taking the equivalent of <30mg/m2/d Hydrocortisone, then they should follow the British Society for Paediatric Endocrinology and Diabetes (BSPED) guidance for sick day rules during times of:

If any child with presumed adrenal insufficiency is:

  • acutely unwell requiring hospital admission OR
  • is unable to take oral mediction OR
  • is receiving a surgical intervention,

then refer to the BSPED guidance on:

Discontinuing steroids

Normal endogenous cortisol secretion resumes in 6-8 weeks in most cases although normal secretion may not resume for 6-12 months, especially in those following prolonged periods of oral steroid treatment (i.e. >12 months) and/or those who have had concurrent treatment with other forms of steroid (eg topical, inhaled or intra-articular etc).

Nearly half of children who discontinue long term oral steroid therapy have an abnormal response to synacthen test despite a weaning regime. There are no known clinical or biochemical factors that predict those with an abnormal response - assume adrenal insufficiency until proven otherwise.

 

Steps to discontinuing long term steroids:

  1. Wean steroid dose down to a physiological dose* (e.g. 2.5 mg/m2/day Prednisolone or equivalent) in the duration that symptoms of the underlying condition permits (or at least 4-6 weeks).
  2. Convert prednisolone to hydrocortisone 10 mg/m2/day in 3 divided doses. Hydrocortisone has a shorter half-life and aids in the recovery of adrenal function.
  3. Update emergency plan in accordance with BSPED guidance on sick day rules.
  4. Wean HC over an 8 to 12 week period, ensuring biggest dose is given in the morning^.

* If steroid regimen involves non-daily dosing (e.g. alternate days or 10 days on/off), then wean until average dose over cycle is equivalent to physiological dose. For example, if currently on alternate day prednisolone, then wean to 5mg/m2/dose before converting to daily hydrocortisone (step 2).

 

^ Hydrocortisone weaning

Oral Hydrocortisone is available in a variety of forms. These include:

  • 20mg tablets
  • 10mg tablets
  • 2.5mg mucco-adhesive buccal tablets ("Corlan" pellets)
  • 2mg/1mg and 0.5mg granules in capsules ("Alkindi").

Granules are only available on a named patient basis. The most practical choice for weaning for children who are on low doses and unable to take tablets is to dissolve 10mg HC in a known quantity of water - discuss with pharmacy.

HC decrements will depend on Starting Dose (SD). The following is a suggested regimen, with example of SD 20mg HC/day given (in brackets):

Week Morning Afternoon Evening
1 0.5*SD (10mg) 0.25*SD (5mg) 0.25*SD (5mg)
2 0.5*SD (10mg) 0.25*SD (5mg) 0.125*SD (2.5mg)
3 0.325*SD (7.5mg) 0.125*SD (2.5mg) 0.125*SD (2.5mg)
4 0.25*SD (5mg) 0.125*SD (2.5mg) 0.125*SD (2.5mg)
5 0.125*SD (2.5mg) 0.125*SD (2.5mg) 0.125*SD (2.5mg)
6 0.125*SD (2.5mg) 0.125*SD (2.5mg) 0mg
7 0.125*SD (2.5mg) 0mg 0mg
8 Stop    
9      
10      
11      
12      

Assess adrenal function

Adrenal function should be assessed via a synacthen test approximately 8 weeks after discontinuing hydrocortisone.

Assume adrenal insufficiency until proven otherwise - children should have an emergency plan in accordance with BSPED guidance until normal adrenal function is demonstrated.

The synacthen test can be completed sooner i.e. after 8 weeks of weaning hydrocortisone. If doing so, omit hydrocortisone the night before and morning of the synacthen test before recommencing hydrocortisone until synacthen results are available.

Alternatively, a random early morning cortisol can be used to guide decision making. If doing so, omit hydrocortisone for 24 hours prior to the test. Early morning cortisol <40nmol/l is strongly suggestive of ongoing adrenal insufficiency, whilst cortisol >250nmol/l is suggestive of normal adrenal function.

Editorial Information

Last reviewed: 05/09/2023

Next review date: 05/09/2025

Author(s): Nicholas Conway.

References

Acknowledgements

This pathway has been developed following discussion with members of the Scottish Paediatric Endocrine Group. We are indebted to the NHS GG&C paediatric endocrinology department for allowing us to adapt their existing pathway for local use.